Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of 2.01% is 48% below its 5-year average of 3.83%, near the low end of its 5-year range (-0.87%–9.15%).
As of the fiscal period ended Sunday, December 28, 2025. 8.22% below its 12-month average of 2.19%.
Annual fiscal-year return on assets; no daily interpolation.
RETURN ON ASSETS (ROA)
2.01%
RETURN ON ASSETS (ROA) AVG TTM
2.19%
RETURN ON ASSETS (ROA) AVG 3Y
1.89%
RETURN ON ASSETS (ROA) AVG 5Y
3.83%
RETURN ON ASSETS (ROA) AVG 10Y
3.90%
RETURN ON ASSETS (ROA) AVG 15Y
3.52%
RETURN ON ASSETS (ROA) AVG 20Y
3.31%
CURRENT VS TTM AVG
-8.22%
CURRENT VS 3Y AVG
+6.63%
CURRENT VS 5Y AVG
-47.52%
CURRENT VS 10Y AVG
-48.44%
CURRENT VS 15Y AVG
-42.83%
CURRENT VS 20Y AVG
-39.36%
SECTOR MEDIAN · HEALTHCARE
4.97%
median of 79 covered companies
CURRENT VS SECTOR MEDIAN
-59.56%
vs the sector median at left
Revvity, Inc.
Market Cap
$12.55B
Return on Assets (ROA)
2.01%
TTM Avg
2.19%
3Y Avg
1.89%
5Y Avg
3.83%
Market Cap
$12.11B
Return on Assets (ROA)
6.44%
TTM Avg
6.68%
3Y Avg
6.69%
5Y Avg
12.75%
Market Cap
$13.51B
Return on Assets (ROA)
-5.37%
TTM Avg
-3.64%
3Y Avg
-1.62%
5Y Avg
0.47%
Market Cap
$11.45B
Return on Assets (ROA)
10.14%
TTM Avg
10.65%
3Y Avg
7.37%
5Y Avg
5.11%
Market Cap
$11.29B
Return on Assets (ROA)
4.30%
TTM Avg
4.54%
3Y Avg
7.94%
5Y Avg
8.21%
Market Cap
$11.20B
Return on Assets (ROA)
-2.39%
TTM Avg
-0.94%
3Y Avg
2.58%
5Y Avg
3.75%
Market Cap
$14.10B
Return on Assets (ROA)
1.89%
TTM Avg
3.10%
3Y Avg
3.02%
5Y Avg
7.71%
Market Cap
$10.37B
Return on Assets (ROA)
-9.07%
TTM Avg
-6.92%
3Y Avg
-1.48%
5Y Avg
0.07%
Market Cap
$14.80B
Return on Assets (ROA)
10.16%
TTM Avg
7.10%
3Y Avg
8.43%
5Y Avg
7.35%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Revvity, Inc. (RVTY) | $12.55B | 2.01% | 2.19% | 1.89% | 3.83% |
| Align Technology, Inc. (ALGN)vs › | $12.11B | 6.44% | 6.68% | 6.69% | 12.75% |
| Baxter International Inc. (BAX)vs › | $13.51B | -5.37% | -3.64% | -1.62% | 0.47% |
| Insulet Corp. (PODD)vs › | $11.45B | 10.14% | 10.65% | 7.37% | 5.11% |
| Bio-Techne Corporation (TECH)vs › | $11.29B | 4.30% | 4.54% | 7.94% | 8.21% |
| Charles River Laboratories International, Inc. (CRL)vs › | $11.20B | -2.39% | -0.94% | 2.58% | 3.75% |
| The Cooper Companies, Inc. (COO)vs › | $14.10B | 1.89% | 3.10% | 3.02% | 7.71% |
| Walgreens Boots Alliance, Inc. (WBA)vs › | $10.37B | -9.07% | -6.92% | -1.48% | 0.07% |
| Solventum Corporation (SOLV)vs › | $14.80B | 10.16% | 7.10% | 8.43% | 7.35% |
| Molina Healthcare, Inc. (MOH)vs › | $10.21B | -0.04% | 5.29% | 6.08% | 6.13% |
ROA
2.0%
ROE
3.4%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-12-28 | 1.99% |
| 2024-12-29 | 2.39% |
| 2023-12-31 | -0.87% |
| 2022-12-31 | 4.03% |
| 2021-12-31 | 6.29% |
| 2020-12-31 | 9.15% |
| 2019-12-31 | 3.48% |
| 2018-12-31 | 4.00% |
| 2017-12-31 | 1.86% |
| 2016-12-31 | 5.46% |
| 2015-12-31 | 5.10% |
| 2014-12-31 | 3.83% |
| 2013-12-31 | 4.25% |
| 2012-12-31 | 1.75% |
| 2011-12-31 | 0.03% |
| 2010-12-31 | 11.96% |
| 2009-12-31 | 2.80% |
| 2008-12-31 | 4.38% |
| 2007-12-31 | 4.51% |
| 2006-12-31 | 4.67% |
| 2005-12-31 | 3.03% |
| 2004-12-31 | 2.95% |
| 2003-12-31 | 2.03% |
| 2002-12-31 | -0.15% |
| 2001-12-31 | -0.02% |
| 2000-12-31 | 4.14% |
| 1999-12-31 | 1.66% |
| 1998-12-31 | 8.96% |
| 1997-12-31 | 4.05% |
| 1996-12-31 | 7.32% |
